- Report
- February 2025
- 221 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- February 2025
- 214 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2025
- 193 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2025
- 189 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2025
- 192 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2025
- 203 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2025
- 200 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- December 2024
- 201 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- December 2024
- 201 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- November 2024
- 192 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- November 2024
- 168 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- November 2024
- 166 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- November 2024
- 200 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- November 2024
- 168 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- October 2024
- 140 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- October 2024
- 157 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- October 2024
- 129 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- October 2024
- 144 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- October 2024
- 130 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- October 2024
- 145 Pages
Global
From €2210EUR$2,500USD£1,908GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more